Research led by the Cleveland Clinic‘s Dr. Charis Eng has led to the discovery of three genetic mutations that are linked to thyroid cancer.
The research involved nearly 3,000 patients with Cowden syndrome, a rare disorder characterized by multiple noncancerous, tumor-like growths that is related to an increased risk of breast and thyroid cancer, according to a statement from the Clinic.
Cleveland Clinic researchers found that mutations in a gene called the “PTEN” are the foundation of Cowden syndrome. PTEN is a tumor suppressor gene that helps direct the growth and division of cells.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The researchers recommend that the thyroids of children with PTEN mutation-causing, Cowden Syndrome-related disease receive increased surveillance.
Eng placed at No. 31 in MedCity News’ list of the “The 50 best Cleveland Clinic doctors. Ever.”
